Altre lingue Devyser Diagnostics AB

Azioni

DVYSR

SE0016588867

Biotecnologia

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 18:00:00 14/01/2025			Variaz. 5gg	Var. 1 gen.
114,00 ^SEK	-0,87%		-5,00%	-3,80%

09:53	Pareto si aspetta un rapporto Q4 forte da Devyser e ribadisce Buy	FW
19/12	Diversi cambiamenti nel Nasdaq First North 25	FW

Altre lingue

Devyser Achieves Class D IVDR Approval for its RHD Product	02/12
Nomination Committee Appointed Ahead of the 2025 Annual General Meeting in Devyser Diagnostics AB	01/11
Devyser Diagnostics AB publishes quarterly report for the period July to September 2024	30/10/24
Devyser Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	30/10/24
Devyser Enters Collaboration to Secure US Approval for Kidney Transplant Monitoring Test	29/10/24
Devyser Enters into Agreement with Thermo Fisher Scientific to Collaborate on Obtaining U.S. Food and Drug Administration Approval for One Lambda? Devyser Accept Cfdna	29/10/24
Devyser Diagnostics AB Achieves Class III Approval in China	28/10/24
Invitation to audiocast for Devyser’s Q3 report 2024	15/10/24
Devyser terminates liquidity guarantee agreement	09/10/24
Devyser Diagnostics - Sticky business worthy of a premium	20/09/24
Devyser Diagnostics Q2 - Entering a potentially case altering phase	01/08/24
Devyser Diagnostics AB publishes quarterly report for the period April to June 2024	23/07/24
Devyser Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	23/07/24
Devyser Diagnostics Wins Cystic Fibrosis Tests Tender in Italy	19/07/24
Devyser Wins Tender in Italy for Its Cystic Fibrosis NGS Test Worth Up to SEK 5.9 Million	19/07/24
Invitation to audiocast for Devyser’s Q2 report 2024	15/07/24
Devyser Wins Tender in Sweden for Thalassemia NGS Testing Worth Up to SEK 8.4 Million	24/06/24
Devyser announces expanded commercial agreement with Thermo Fisher Scientific for post-transplant monitoring NGS products	17/06/24
Devyser Diagnostics AB Announces Expanded Commercial Agreement with Thermo Fisher Scientific for Post-Transplant Monitoring NGS Products	17/06/24
Devyser Launches Updated Y-Chromosomal Microdeletion Test	14/06/24
Devyser Wins Up to SEK75 Million Tender for Diagnostic Systems in Italy	13/06/24
Devyser Wins All-Time High Tender for Up to SEK 75 Million	13/06/24
Devyser Wins Tender for Oncology NGS Solutions in Italy	30/05/24
Devyser Wins Tender for Thalassemia in Italy	27/05/24
Bulletin from the Annual General Meeting of Devyser Diagnostics AB (publ) held on 14 May 2024	14/05/24

Iscriviti per accedere a più notizie

Registrazione 100% gratuita

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Devyser Diagnostics AB

Azioni

DVYSR

SE0016588867

Biotecnologia

Altre lingue

Filtri